Jane Street Group, LLC Zai Lab LTD Call Options Transaction History

Jane Street Group, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 16, 2022	SELL	$23.14 - $49.68 $196,690 - $422,280	-8,500 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$27.77 - $64.4 $169,397 - $392,840	-6,100 Reduced 41.78%	8,500 $374,000
Q4 2021 Feb 15, 2022	SELL	$54.9 - $105.21 $3.21 Million - $6.15 Million	-58,500 Reduced 80.03%	14,600 $918,000
Q3 2021 Nov 16, 2021	SELL	$105.0 - $178.37 $4.43 Million - $7.53 Million	-42,200 Reduced 36.6%	73,100 $7.7 Million
Q2 2021 Aug 16, 2021	BUY	$125.11 - $180.0 $12.3 Million - $17.7 Million	98,200 Added 574.27%	115,300 $20.4 Million
Q1 2021 May 18, 2021	BUY	$126.27 - $191.71 $1.53 Million - $2.32 Million	12,100 Added 242.0%	17,100 $2.28 Million
Q4 2020 Feb 17, 2021	SELL	$81.94 - $135.34 $1.19 Million - $1.96 Million	-14,500 Reduced 74.36%	5,000 $677,000
Q3 2020 Nov 17, 2020	BUY	$73.3 - $89.48 $1.43 Million - $1.74 Million	19,500 New	19,500 $1.62 Million

113

40.9M

63.1K

420K

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.